A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7-Reference-Cited by-同舟云学术

A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

Published:2007-01 Issue:2 Volume:136 Page:203-211
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shustik Chaim,Belch Andrew,Robinson Sue,Rubin Sheldon H.,Dolan Sean P.,Kovacs Michael J.,Grewal Kuljit S.,Walde David,Barr Robert,Wilson Jonathan,Gill Kulwant,Vickars Linda,Rudinskas Leona,Sicheri Dolores A.,Wilson Kenneth,Djurfeldt Marina,Shepherd Lois E.,Ding Keyue,Meyer Ralph M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06405.x/fullpdf

Reference24 articles.

1. Primary dexamethasone treatment of multiple myeloma

2. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

3. Overexpression of the ERG Gene Is an Adverse Prognostic Factor in Acute Myeloid Leukemia (AML) with Normal Cytogenetics (NC): A Cancer and Leukemia Group B Study (CALGB).

4. Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

5. A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From mechanism to resistance – changes in the use of dexamethasone in the treatment of multiple myeloma;Leukemia & Lymphoma;2022-10-28

2. Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma;Journal of Clinical Medicine;2022-09-29

3. A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022;Expert Review of Anticancer Therapy;2022-05-03

4. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia;Frontiers in Immunology;2021-10-25

5. Maintenance Strategies After Hematopoietic Cell Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2020-05-19